Concepedia
Statistics
Publications
8
Citations
293
H-Index
Active since
2001
Affiliations
Eli Lilly (United States)(Current)
TiGenix (Spain)
NVE Corporation (United States)
University of Southern California
Lida Etemad is an author at Eli Lilly (United States) specializing in pharmacoeconomics, medicine, and healthcare cost analysis.
Publications per year
2001–2021
Total First-Year Costs of Acute Coronary Syndrome in a Managed Care Setting
Lida Etemad, Patrick L. McCollam · Journal of Managed Care Pharmacy · 2005 · 77 citations · Full text
Medicine, Cardiology, Pharmacoeconomics +10
Opioid-Mediated Facilitation of Long-Term Depression in Rat Hippocampus
John J. Wagner, Lida Etemad, Angela Thompson · Journal of Pharmacology and Experimental Therapeutics · 2001 · 48 citations
Life Sciences, Neurobiology, Neuroscience +17
Cost-Effectiveness Analysis of Pharmaceutical Care in a Medicare Drug Benefit Program
Lida Etemad, Joel W. Hay · Value in Health · 2003 · 45 citations · Full text
Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +16
Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
Lida Etemad, Winnie Yang, Denise Globe et al. · Journal of Managed Care Pharmacy · 2005 · 35 citations · Full text
Pharmacy, Pharmacoeconomics, Pharmacotherapy +17
Dose adjustment over time of etanercept and infliximab in patients with rheumatoid arthritis.
Lida Etemad, Elaine Yu, Lee A. Wanke · PubMed · 2005 · 29 citations
Medicine, Pharmacoeconomics, Pharmacotherapy +17
1–5 of 8